## Core Concept
Prophylactic cranial irradiation (PCI) is a treatment approach used to prevent or delay the development of brain metastases in certain types of cancer. It involves the irradiation of the entire brain to eliminate microscopic cancer cells that may have spread to the brain.

## Why the Correct Answer is Right
Small cell lung cancer (SCLC) is a type of lung cancer that is known to have a high propensity for brain metastasis. PCI has been shown to improve survival and reduce the incidence of brain metastases in patients with SCLC, particularly those with limited-stage disease. In contrast, non-small cell lung cancer (NSCLC) has a lower propensity for brain metastasis, and the role of PCI in NSCLC is more limited.

## Why Each Wrong Option is Incorrect
* **Option A:** Small cell lung cancer (SCLC) - PCI is indicated in SCLC, especially in patients with limited-stage disease, as it improves survival and reduces brain metastases.
* **Option B:** Medulloblastoma - PCI is often used in the treatment of medulloblastoma, a type of brain tumor, to reduce the risk of spinal cord and brain metastases.
* **Option C:** Acute lymphoblastic leukemia (ALL) - PCI may be used in the treatment of ALL, particularly in patients with high-risk disease or those with central nervous system (CNS) involvement.

## Why Option D is Correct
* **Option D:** Non-small cell lung cancer (NSCLC) - PCI is not routinely indicated in the treatment of NSCLC, except in certain cases with specific indications, such as in patients with stage III disease and without evidence of brain metastases.

## Clinical Pearl / High-Yield Fact
A key point to remember is that PCI is primarily used in SCLC and certain other malignancies with a high risk of CNS metastasis. In NSCLC, targeted therapies and other treatments have changed the landscape, making routine use of PCI less common.

## Correct Answer: D. Non-small cell lung cancer.